Amir Kalali Person-Info 

( Ich bin Amir Kalali)

News

Clarification on Regulatory Decisions on Antipsychotic Trials Brought...

www.finanznachrichten.de
A half-day symposium on emerging regulatory practice around approvals for antipsychotic compounds was held March 4, 2009, at the Annual Meeting of the...

Bracket Expands Team with Industry Leader Dr. Amir Kalali, by...

weblog.ceo.ca
WAYNE, Pa., Sept. 6, PRNewswire/ -- Bracket, a leading clinical trial technology and specialty services provider, today introduced Amir Kalali, MD,...

Ramius Offers to Acquire Cypress Bioscience for $4.00 Per Share in...

www.finanznachrichten.de
Offer represents a 60% premium over the last closing price and 74% premium over the average closing price since the acquisition of BioLineRx's BL drug...
Dossier exportieren
+1